Skip to main content

Table 3 Pregnancy outcomes and maternal complications by SCD status of women who delivered in the hospital

From: Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India

  

SCD N (%)

Sickle cell trait N (%)

Non-SCD N (%)

Type of birth

Live birth

118 (90.1)

1573 (95.6)

8001 (96.9)

Stillbirth

13 (9.9)

72 (4.4)

258 (3.1)

Blood transfusion

No

62 (47.3)

1575 (95.8)

7998 (97.1)

Yes

69 (52.7)

69 (4.2)

239 (2.9)

Number of blood transfusion

0

62 (47.3)

1575 (95.8)

7998 (97.1)

1–2

58 (44.3)

67 (4.1)

221 (2.7)

3 and more

11 (8.4)

2 (0.1)

18 (0.2)

Birth weight

≤1499 g

11 (8.4)

76 (4.6)

351 (4.2)

1500–1999 g

19 (14.5)

125 (7.6)

648 (7.8)

2000–2499 g

62 (47.3)

520 (31.6)

2627 (31.8)

≥2500 g

39 (29.8)

924 (56.2)

4633 (56.1)

Gestational weeks

Pre-term (≤36 weeks)

59 (45.0)

287 (17.4)

1466 (17.7)

Full-term (37–42 weeks)

72 (55.0)

1355 (82.4)

6789 (82.2)

Post-term (>42 weeks)

0 (0.0)

3 (0.2)

5 (0.1)

Caesarean section

No

108 (82.4)

1553 (94.4)

7754 (93.9)

Yes

23 (17.6)

92 (5.6)

506 (6.1)

Sickle crisis

No

69 (52.7)

NA

NA

Yes

62 (47.3)

NA

NA

Intrauterine growth retardation

No

128 (97.7)

1614 (98.1)

8126 (98.4)

Yes

3 (2.3)

31 (1.9)

134 (1.6)

Pregnancy-induced hypertension

No

123 (93.9)

1509 (91.7)

7578 (91.7)

Yes

8 (6.1)

136 (8.3)

682 (8.3)

Eclampsia

No

128 (97.7)

1628 (99)

8172 (98.9)

Yes

3 (2.3)

17 (1)

88 (1.1)

Preterm labour pain

No

130 (99.2)

1643 (99.9)

8254 (99.9)

Yes

1 (0.8)

2 (0.1)

6 (0.1)

  1. NA not applicable